Smad6 and Smad7 comprise a subclass of vertebrate Smads that antagonize, rather than transduce, TGF-b family signaling. These AntiSmads can block BMP signaling, as evidenced by their ability to induce a secondary dorsal axis when misexpressed ventrally in Xenopus embryos. Smad7 inhibits additional TGF-b related pathways, and causes spina bi®da when misexpressed dorsally. We have performed structure-function analyses to identify domains of Anti-Smads that are responsible for their shared and unique activities. We ®nd that the Cterminal domain of Smad7 displays strong axis inducing activity but cannot induce spina bi®da. The isolated N-terminal domain of Smad7 is inactive but restores the ability of the C-terminus to cause spina bi®da when the two are co-expressed. By contrast, the N-and C-terminal domains of Smad6 have weak axis inducing activity when expressed individually, but show full activity when co-expressed. Chimeric analysis demonstrates that the C-terminal domain of Smad7, but not Smad6, can induce spina bi®da when fused to the N-terminal domain of either Smad6 or Smad7. Thus, although the C-terminal domain is the primary determinant of the intrinsic activity of Xenopus Anti-Smads, the N-terminal domain is essential for full activity, is interchangeable between Smad6 and 7, and can function in trans. q
Introduction
Members of the transforming growth factor-b (TGF-b) superfamily of cell-cell signaling molecules play critical roles in specifying cell fate during embryogenesis. Bone morphogenetic protein-4 (BMP-4), for example, is required for ventral mesoderm formation and for repression of neural fate (reviewed by Graff, 1997) . When BMP-4 activity is blocked in ventral cells of Xenopus embryos, ventral fates are eliminated and a secondary dorsal axis forms. In addition, when BMP-4 signaling is blocked in prospective epidermal cells, these cells instead differentiate into neural tissue. The Drosophila ortholog of BMP-4, decapentaplegic (Dpp) plays a conserved role in dorsoventral patterning (reviewed by Ferguson, 1996) . Other members of the TGF-b family, such as activin, Vg1 and nodal-related factors, have been implicated in mesendoderm induction and patterning (Harland and Gerhart, 1997) . Overexpression of these ligands in Xenopus ectodermal explants induces mesoderm formation whereas inhibition of intracellular signaling pathways downstream of these ligands blocks mesoderm differentiation.
TGF-b family signals are transduced inside of cells following binding to receptors that consist of complexes of type I and type II transmembrane serine-threonine kinases (reviewed by . Following ligand binding, type II receptors transphosphorylate type I receptors that then propagate the signal. A novel group of structurally related proteins, referred to as Smads, plays a critical role in transmitting TGF-b family signals from cell-surface receptors to the nucleus (reviewed by Piek et al., 1999; Kawabata and Miyazono, 1999) . Based on structural and functional features, Smads have been divided into three subclasses. The ®rst two subclasses are pathwayrestricted or receptor-regulated Smads (R-Smads: Smad1, 2, 3, 5, and 8 in vertebrates; Mothers against dpp [Mad] and dSmad2 in Drosophila) and common Smads (Co-Smads: Smad4 in vertebrates and Medea in Drosophila). Activated TGF-b family receptors directly phosphorylate speci®c RSmads. Smad1, 5, and 8 are phosphorylated downstream of BMP signals whereas Smad2 and 3 are activated in response to TGF-b or activin. Phosphorylated R-Smads oligomerize with a Co-Smad, translocate to the nucleus and participate as components of transcription factor complexes to activate or repress target gene expression (Attisano and Wrana, 2000; Massague Â and Wotton, 2000) .
A third subclass of Smads, consisting of vertebrate Smad6 and Smad7, and Drosophila Daughters against Dpp (Dad), can all inhibit BMP/Dpp signaling (reviewed by Christian and Nakayama, 1999) . These Anti-Smads (also known as Inhibitory Smads) bind stably to the intracellular domain of activated BMP/Dpp type I receptors, thereby preventing receptor-mediated activation of RSmads, complex formation with Co-Smads and nuclear translocation (Imamura et al., 1997; Inoue et al., 1998; Souchelnytskyi et al., 1998) . Smad6 also binds Smad1 in response to BMP signaling, thereby preventing formation of an active Smad1-Smad4 complex (Hata et al., 1998) , and can function as a transcriptional corepressor to antagonize BMP signaling in the nucleus (Bai et al., 2000) .
In addition to inhibiting signal transduction downstream of BMPs, Smad7, and possibly Smad6, can target other TGF-b family pathways. Smad6 and Smad7 have both been shown to bind TGF-b/activin type I receptors, thereby inhibiting phosphorylation of Smad2 and/or 3 (Hayashi et al., 1997; Imamura et al., 1997; Nakao et al., 1997) . Smad7 inhibits activin-induced growth arrest and apoptosis of mouse B cells (Ishisaki et al., 1998 (Ishisaki et al., , 1999 and phenocopies the effects of blocking activin-like signaling pathways in Xenopus embryos (Nakao et al., 1997; Casellas and Hemmati Brivanlou, 1998; Bhushan et al., 1998; Nakayama et al., 1998b) . Overexpression of Smad7 in Xenopus embryos also causes distinct patterning defects, such as spina bi®da and inhibition of gastrulation, which cannot be attributed to loss of endogenous activin, TGF-b or BMP signaling (Nakayama et al., 1998b) . Thus, Smad7 may target discrete, as of yet unidenti®ed, signaling pathways. Although Smad6 can partially block activin signaling in Xenopus embryos (Nakayama et al., 1998a) , a variety of evidence suggests that endogenous Smad6 may preferentially or selectively inhibit the BMP pathway (Hata et al., 1998; Ishisaki et al., 1999) .
R-and Co-Smad proteins consist of highly conserved amino (N)-terminal and carboxy (C)-terminal domains, termed MH1 (for Mad homology 1) and MH2 domains respectively, that are separated by a less conserved linker region. Structural and functional analyses have shown that the MH1 domain participates in DNA binding whereas the MH2 domain is required for transcriptional activation, homo-and hetero-oligomerization and interaction with receptors, other DNA binding proteins, transcriptional coactivators and corepressors. In the basal state, reciprocal interactions between the MH1 and MH2 domains maintain Smads in an inactive form which is relieved by receptor mediated phosphorylation (reviewed by Piek et al., 1999; Kawabata and Miyazono, 1999) .
Anti-Smads can also be divided into MH1, linker, and MH2 domains which are poorly conserved across species and share only minimal homology with other classes of Smads (reviewed by Christian and Nakayama, 1999; Nakayama et al., 2000) . Several short sequence motifs have been identi®ed that are unique to Anti-Smads but the function of these is unknown. Preliminary studies suggest that the C-terminal region of Anti-Smads may be suf®cient for biological activity whereas the N-terminal region may play an inhibitory role or determine speci®city for a given signaling pathway Hata et al., 1998; Souchelnytskyi et al., 1998) . In this report, we have performed structure-function analyses to identify functional domains of Xenopus Smad6 and Smad7 that are required for their unique activities. Our data demonstrate that the C-terminal domain is the primary determinant of the intrinsic activity of Xenopus Anti-Smads, but is not suf®cient for all biological activities. We show that the N-terminal domain is essential for full activity of Anti-Smads, is exchangeable between Smad6 and 7, and can function in trans.
Results

The MH1 domain of Xenopus Smad7 is not required for inhibition of BMP signaling
The isolated C-terminal domain (amino acids 204±426) of mammalian Smad7 is suf®cient for receptor binding and inhibition of BMP signaling (Souchelnytskyi et al., 1998) . To determine whether the same is true for Xenopus Smad7, we tested the activity of an MH1-deleted protein (Smad7 DN) consisting of the C-terminal portion of the linker region and the whole MH2 domain (amino acids 172± 382, shown schematically in Fig. 1A ). This region shares 93% amino acid identity with the corresponding region of mammalian Smad7 (amino acids 216±426). Inhibition of BMP signaling in ventral cells of whole Xenopus embryos results in induction of a secondary dorsal axis and/or a hyperdorsalized phenotype in which the trunk and tail are severely reduced or lost. Injection of RNA encoding Smad7 DN into ventral blastomeres of four-cell Xenopus embryos caused secondary dorsal axis formation (Fig. 1B , DN, arrowhead) and/or hyperdorsalization (Fig. 1B, DN , arrow) similar to that observed following injection of full-length RNA (Fig. 1B, Full ; Table 1 ). Injection of as little as 1 pg of Smad7 DN RNA was suf®cient to cause secondary axis formation, and injection of successively higher doses of RNA up to 4 pg led to a corresponding increase in the frequency of dorsalization (Table 1) . Embryos injected ventrally with 25 pg or more of Smad7 DN RNA died during gastrulation (data not shown). In contrast, when up to 2000 pg of RNA encoding the complementary N-terminal region of Smad7 (Smad7 N, amino acids 1±172, Fig. 1A ) was injected near the ventral marginal zone (VMZ) at the four-cell stage, embryos developed normally (Fig. 1B,N , Table 1 ).
To further examine the ability of deletion mutant forms of Smad7 to inhibit BMP signaling, we asked whether they could induce expression of a neural-speci®c marker gene in ectodermal explants (animal caps). Full-length Smad7 and Smad7 DN, but not Smad7 N, induced expression of the panneural marker NCAM in animal caps (Fig. 1C) . Smad7 DN appeared to be much more potent than Smad7 since injection of 1±4 pg of Smad7 DN RNA dorsalized whole embryos (Fig.   1B , Table 1 ) and induced expression of NCAM in animal caps (Fig. 1C) at levels comparable to that observed following injection of 200 pg of Smad7 RNA. This may not re¯ect an increase in the intrinsic activity of Smad7 DN, however, since western blot analysis showed that Smad7 DN and Smad7 N protein accumulated to much higher steady state levels than did Smad7 following injection of equivalent amounts of each RNA (data not shown). From these data, we conclude that the MH1 domain of Xenopus Smad7 is not required for inhibition of BMP signaling. 
Both N-and C-terminal regions of Xenopus Smad6 are required for activity
To determine whether the MH1 domain of Xenopus Smad6 is dispensable for inhibition of BMP signaling in vivo, we tested the activity of two different N-terminally deleted forms of Xenopus Smad6 that are illustrated schematically in Fig. 2A . Smad6 DN encodes a protein that begins with the original initiation methionine but lacks almost the entire MH1 domain and the N-terminal portion of the linker (amino acids 5±152). Smad6 DN2 also begins with the original initiation methionine but lacks the N-terminal three quarters of the MH1 domain (amino acids 2±98).
Injection of up to 2000 pg of RNA encoding Smad6 DN or Smad6 DN2 into ventral blastomeres of four-cell Xenopus embryos induced a secondary dorsal axis in only 2±15% of embryos (Table 2) . By contrast, ventral injection of 200 pg of full-length Smad6 RNA induced secondary axes and/or hyperdorsalization in more than 80% of embryos ( Fig. 2B ; Table 2 ). The low activity of these deletion mutants was unexpected since the isolated C-terminal domain of human Smad6 (amino acids 272±496; corresponding to amino acids 132±354 of Xenopus Smad6) is more potent than native Smad6 in the same dorsal axis inducing assay (Hata et al., 1998) . The comparable region of Xenopus Smad6, which shares 70% identity with human Smad6, is also reported to be hyperactive in this assay (Hata et al., 1998) .
Surprisingly, a deletion mutant form of Smad6 consisting of the MH1 domain plus a small portion of the linker (Full) and deletion mutant forms of Smad6 (not drawn to scale). Numbers indicate amino acid residues. Several constructs contain short stretches of unrelated amino acids at the C-terminus or in the splice site as indicated in the schematic drawing. The ability of each protein to induce a dorsalized phenotype (Table 2) is summarized to the right of each construct (1111, full activity; 111, almost full activity; 1, moderate activity;^, minimal activity; 2, no activity). (Smad6 N, amino acids 1±153, illustrated in Fig. 2A ) induced formation of a secondary axis in a dose-dependent manner in up to 40% of embryos ( Table 2) . Deletion of an additional 39 amino acids from the C-terminus of Smad6 N (Smad6 N2, Fig. 2A ) completely abolished axis inducing activity ( Table 2 ), suggesting that amino acids 115±153 are essential for function. Consistent with this possibility, deletion of these same amino acids from full-length Smad6 (Smad6 IntD, Fig. 2A ) rendered it inactive (Table 2) .
To test whether the low activity of deletion mutant forms of Smad6 is due to inef®cient translation and/or instability of the truncated proteins and/or RNAs, we analyzed steady state levels of ectopically expressed, myc epitope-tagged proteins and RNA by western blot analysis and RT-PCR, respectively (Fig. 3A) . As shown in Fig. 3B , deletion mutant forms of Smad6 protein accumulated to much higher levels than did native Smad6 (top panel) despite the fact that RNA encoding each protein was present at equivalent levels in gastrula stage embryos (bottom panel). It is unlikely that these differences in protein accumulation re¯ect differences in translation between the four RNAs since they possess identical 5 H and 3 H untranslated regions. We conclude that the relatively low biological activity of deletion mutant forms of Smad6 is not due to inef®cient expression of the proteins.
Interestingly, we found that Smad6 N and DN can complement each other and inhibit BMP signaling when expressed in trans. When RNAs encoding Smad6 N and DN were co-injected near the VMZ at the four-cell stage, the majority of injected embryos developed secondary axes and/or a dorsalized phenotype ( Fig. 2A ; Table 2 ). This is not merely an additive effect since injection of 1000 pg of either RNA alone rarely induced a dorsalized phenotype whereas co-injection of 500 pg of each RNA induced a dorsalized phenotype in over 80% of embryos (Table 2 ). This synergistic effect provides further evidence that the low activity of Smad6 DN or N is not due to insuf®cient accumulation of either protein. Unlike Smad6 N, Smad6 N2 cannot complement Smad6 DN to restore BMP inhibitory activity since only a minority of embryos co-injected with up to 2000 pg of RNA encoding these two deletion mutants formed a secondary axis ( Fig. 2A ; Table 2 ). Unexpectedly, co-injection of up to 2000 pg of RNA encoding Smad6 N2 and Smad6 DN2 also failed to induce secondary axis formation, despite the fact that together these two deletion mutants contain the entire coding region for Smad6. The latter two results further support the possibility that amino acids 115± 153 are critical for function (since Smad6 N, but not N2 can complement Smad6 DN) and suggest that these residues can only function when present in cis to the MH1 domain (since Smad6 N2 and DN2 are inactive even when co-expressed). To further assay the ability of Smad6 N and Smad6 DN to inhibit BMP signaling in trans, we compared NCAM induction in ectodermal explants isolated from embryos injected with RNA encoding native Smad6 (200 pg), Smad6 N or Smad6 DN alone (2000 pg), or Smad6 N and Smad6 DN together (500 pg each). As shown in Fig. 2C , very low levels of NCAM transcripts were induced in animal caps made to express Smad6 N or Smad6 DN alone, whereas NCAM levels in animal caps made to co-express these two deletion mutants were equivalent to those induced by native Smad6. Expression of NCAM re¯ects the direct neuralizing activity of Smad6, and is not an indirect consequence of mesoderm induction since expression of the mesodermal marker aactin, was not observed in any case (Fig. 2C) . We conclude that the isolated N-and C-terminal domains of Smad6 can function in trans to potently inhibit BMP signaling in vivo.
The isolated C-terminal domain of Xenopus Smad7 is not suf®cient for all Smad7 activities
In contrast to Smad6, which preferentially inhibits the BMP pathway, Smad7 potently inhibits signaling downstream of BMPs, activin and TGF-b (see Section 1). Smad7 also antagonizes at least one other, as of yet unidenti®ed signaling pathway since misexpression of Smad7 in dorsal cells of Xenopus embryos causes spina bi®da (Nakayama et al., 1998b) whereas misexpression of speci®c antagonists of BMP, activin or TGF-b signaling does not cause this phenotype.
To determine whether the isolated C-terminal domain of Smad7 possesses all of the properties of the native protein, we asked whether Smad7 DN causes spina bi®da when misexpressed in dorsal cells of Xenopus embryos. Injection of RNA (200 pg) encoding Smad7 into dorsal cells at the four-cell stage caused spina bi®da ( Fig. 4A and Table 3 ) and eye defects (Fig. 4A ) whereas embryos injected dorsally with 200 pg ( Fig. 4B; Table 3 ) or 2000 pg (data not shown) of Smad7 N RNA developed normally. By contrast, embryos injected dorsally with 200 pg of Smad7 DN RNA showed eye defects (Fig. 4C ), but spina bi®da was never observed (Table 3 ). This is in striking contrast to the behavior of Smad7 DN in ventral cells where as little as 1 pg of Smad7 DN RNA can phenocopy the effect of much higher doses of native Smad7, and injection of greater than 25 pg of RNA is lethal (Table 1 ). This result suggests that Smad7 DN retains some, but not all of the activities of native Smad7 in dorsal cells.
To test the possibility that the C-and N-terminal domains of Smad7 can function in trans to restore full Smad7 activity, we co-injected RNAs encoding Smad7 N and Smad7 DN (200 pg each) near the dorsal midline of four-cell embryos. All of these embryos developed spina bi®da ( Fig. 4D and Table 3 ), demonstrating that these two deletion mutants can complement each other when co-expressed. We conclude that although the N-terminal domain of Smad7 is Fig. 4 . N-and C-terminal domains of Smad7 are required for induction of spina bi®da. RNA encoding native or deletion mutant forms of Smad7, as indicated above each panel (not drawn to scale), were injected near the dorsal marginal zone (DMZ) (A±D,F) or VMZ (E) of four-cell embryos which were then cultured to the tadpole stage. Photographs of representative embryos are shown. dispensable for Smad7-mediated inhibition of BMP signaling in Xenopus embryos, it is essential for other activities, and can function in trans to the C-terminal domain of Smad7.
To narrow down the region of the N-terminus of Smad7 that is required for induction of spina bi®da, we tested the activity of an internal deletion mutant form of Smad7 (Smad7 IntD) which lacks amino acids 161±203 as illustrated in Fig. 4E ,F. Ventral injection of RNA (250 pg) encoding Smad7 or Smad7 IntD (Fig. 4E ) into whole Fig. 4E ,F) was injected near the VMZ or DMZ of four-cell embryos which were then cultured to the tadpole stage and scored for secondary axis and hyperdorsalization or spina bi®da. The number of injected embryos that survived to the tadpole stage (N) and the percentage of these embryos that showed secondary axis/hyperdorsalization or spina bi®da are indicated. a RNA encoding native or deletion mutant forms of Smad7 was injected near the DMZ of four-cell embryos. The number of injected embryos that survived to the tadpole stage (N) and the percentage of these embryos that showed spina bi®da are indicated.
embryos led to induction of a secondary dorsal axis or hyperdorsalization at comparable frequencies (Table 4) . By contrast, injection of RNA encoding Smad7 IntD RNA (250 pg) into dorsal cells induced eye defects in most embryos (Fig. 4F ), but spina bi®da was never observed (Table 4) . These results, together with the observation that Smad7 DN (amino acids 172±382) can induce a secondary axis (Table 1) but not spina bi®da (Table 3 ), suggest that amino acids 161±171 within the linker region of Smad7 are dispensible for inhibition of BMP signaling but are essential for inducing spina bi®da.
The N-terminal domains of Smad6 and Smad7 are exchangeable
As shown above, the C-terminal domain of Smad7 is suf®cient to inhibit BMP signals and induce ventral cells to form a secondary axis, whereas induction of spina bi®da requires the N-terminal domain. This ®nding raised the possibility that the N-terminus of Smad7 is responsible for the unique ability of Smad7, but not Smad6, to induce spina bi®da. To test this possibility, we made chimeric constructs consisting of the N-terminal domain of Smad7 fused in frame to the C-terminal domain of Smad6 (Smad7/6), or vice versa (Smad6/7), as illustrated in Fig. 5A ,C. The Nterminal domains of Smad6 and Smad7 share approximately 40% amino acid identity with each other.
When RNA encoding Smad7/6 (200 pg) was injected near the dorsal midline of four-cell embryos, these embryos developed completely normally ( Fig. 5A ; Table 5 ), as did embryos injected with the same amount of Smad6 RNA ( Fig. 5B ; Table 5 ). By contrast, injection of RNA (200 pg) encoding Smad6/7 (Fig. 5C) or Smad7 (Fig. 5D) induced spina bi®da at a high frequency (Table 5 ). These results suggest that the C-terminal, rather than the N-terminal , or Smad7/6 (300 pg) was injected near the animal pole of two-cell embryos. Animal caps were isolated at the blastula stage and cultured to stage 26 as illustrated. RNAs were extracted from pooled caps and control embryo and subjected to RT-PCR analysis. Fig. 5) were injected near the DMZ of four-cell embryos which were then cultured to the tadpole stage and scored for spina bi®da. The number of injected embryos that survived to the tadpole stage (N) and the percentage of these embryos that showed spina bi®da are indicated. domain of Smad7 contains the primary determinants of its unique ability to induce spina bi®da.
To test whether the N-terminus of Smad7 can function together with the C-terminus of Smad6 to inhibit BMP signaling, we analyzed the ability of chimeric constructs to induce a secondary dorsal axis in whole embryos and to induce neural-speci®c gene expression in animal caps. Ventral injection of RNA (100 pg) encoding either Smad6/7 or Smad7/6 into whole embryos led to induction of a secondary dorsal axis (Fig. 6B ) with a frequency comparable to that of native Smad7 or Smad6 (Table 6) . Furthermore, injection of RNA encoding Smad7/6 (300 pg), Smad6/7 (150 pg), Smad6 (200 pg) or Smad7 (200 pg) led to induction of expression of the neural marker gene, NCAM, in ectodermal explants (Fig. 6C ). Smad6 and Smad7/6 were less potent than Smad7 and Smad6/7 in the neural induction assay, although they possessed comparable activities in the dorsal axis induction assay. Taken together, our data demonstrate that the N-terminal domains of Smad6 and Smad7 can interchangeably rescue the full BMP-inhibitory activity of the C-terminus of Smad6, and can rescue the ability of the C-terminus of Smad7 to induce spina bi®da. We conclude that the primary determinants of the speci®city of Anti-Smads for different signaling pathways lies in the Cterminal domain of these proteins but that the N-terminus is required for full function.
Discussion
A variety of evidence suggests that the C-terminal domain of Anti-Smads is an effector domain, whereas the N-domain has an inhibitory effect and/or confers speci®city for distinct signaling pathways. The isolated C-domain of human Smad6, for example, binds constitutively to Smad1 and is suf®cient to inhibit BMP signal transduction, whereas full length Smad6 binds to Smad1 only when the BMP pathway has been activated (Hata et al., 1998) . Thus, deletion of the N-terminal domain of Smad6 relieves the ligand dependence of signal inhibition. The C-terminal domain of Smad6 is also suf®cient for binding to Hoxc-8, thereby preventing Smad1 from interacting with Hoxc-8 and activating transcription. Interaction of full length Smad6 with Hoxc-8 is much weaker, again consistent with an inhibitory role for the N-domain (Bai et al., 2000) . Likewise, an intact C-terminal domain of Smad7 has been shown to be necessary (Hayashi et al., 1997) and suf®cient (Souchelnytskyi et al., 1998) for association with TGF-b family receptors and signal inhibition. Recent studies have also shown that an intact C-terminal domain of Smad7 is required for interaction with STRAP, a protein that stabilizes the interaction of Smad7 with the intracellular domain of TGF-b receptors and thus potentiates its inhibitory effects (Datta and Moses, 2000) . Finally, the observation that Xenopus and murine Smad7, which share 96% identity within the C-terminal domain and much less identity within the N-terminal domain, show different biological activities in Xenopus embryo overexpression assays (Nakayama et al., 1998b; Souchelnytskyi et al., 1998) was interpreted to suggest that the C-terminal domain is an effector whereas sequences within the N-terminal domain confer speci®city for distinct signaling pathways.
Our current data support the idea that the C-domain of Anti-Smads is primarily responsible for biological activity. We show, however, that the N-domain does not function as an inhibitor and/or a determinant of signaling speci®city, but is instead essential for full activity. An N-terminal domain is required, for example, for the C-terminal domain of Smad7 to induce spina bi®da or for the C-terminal domain of Smad6 to inhibit BMP signaling. The latter observation is curious given that a comparable or smaller C-terminal domain of Xenopus Smad7, murine Smad7, and human Smad6 is suf®cient for inhibition of BMP signaling in Xenopus embryos. The observation that addition of the Nterminal domain of Smad6 can restore full activity to the Cterminal domain of Smad7, and vice versa, clearly demonstrates that the speci®city of a given Anti-Smad for a particular signaling pathway is intrinsic to the C-terminal domain. In addition to being required for full C-domain function, we found that the isolated N-domain of Smad6 is itself functional. This ®nding was unexpected and raises the possibility that the recently reported targeted disruption of the murine Smad6 gene is not a true null allele since only the MH2 domain was deleted (Galvin et al., 2000) .
The molecular mechanism by which the N-terminal domain contributes to the activity of Anti-Smads is unknown but several possibilities can be imagined. First, it is possible that the N-domain interacts with the C-domain to establish an active conformation that is required for some Anti-Smad functions. If this is the case, these two domains must physically interact even when non-covalently attached since we have shown that the N-and C-domains can function in trans when co-expressed. Consistent with this possibility, the MH1 domains of Smad2 and 4 can directly bind to their respective MH2 domains (Hata et al., 1997) . We have attempted to co-immunoprecipitate Smad6 N and Smad6 DN and have found no evidence that these domains interact either in vitro or in vivo. An alternate mechanism by which the N-domain of AntiSmads might function is to recruit a co-factor that is essential for some Anti-Smad functions. Conversely, the Ndomain might bind to, and thus prevent an inhibitory factor from interacting with the C-terminal domain in vivo. This latter possibility might account for our observation that the isolated N-domain of Smad6 has biological activity in overexpression assays, since it could conceivably displace an inhibitory protein bound to the C-terminus of endogenous Smad6 and thereby unmask its intrinsic activity. This possibility might also explain the ability of the isolated Cterminal domain of mammalian, but not Xenopus, Smad6 to inhibit BMP signaling in Xenopus embryos if this hypothetical binding protein can only recognize the Xenopus C-terminus due to species speci®c sequence differences.
Our data show that speci®c sequence elements (amino acids 115±153) must be covalently attached to the N-terminal region of Smad6 to generate a functional domain. Furthermore, we show that amino acids 161±171 of Smad7 are essential for its ability to induce spina bi®da. The functional N-termini of Smad6 and Smad7 contain several highly conserved sequence motifs that are found only in Anti-Smads (consensus AVESRGG, corresponding to amino acids 61±67 and 81±87 of Xenopus Smad6 and Smad7, and consensus ESPPPPYSR, corresponding to amino acids 134±142 and 161±169 of Xenopus Smad6 and Smad7, respectively) (Nakayama et al., 2000) . These motifs may act as important determinants of N-domain function, possibly by creating binding pockets for accessory proteins. The conserved ESPPPPYSR sequence, for example, contains a PPPY motif that is a possible binding site for WW domain-containing proteins (Staub and Rotin, 1996) . Notably, the SMAD ubiquitin ligase, Smurf1, is a WW domain-containing protein that binds to a PPXY motif in the R-Smad, Smad1, thereby targeting it for degradation by the 26S proteosome (Zhu et al., 1999) . Our observation that deletion of a region of Smad6 or Smad7 encompassing this motif reduces or ablates activity raises the possibility that the function of Anti-Smads may be regulated by a WW domain-containing protein(s). Further identi®cation of binding proteins that modulate the activities of Anti-Smads will help to clarify these issues. Regardless of the mechanism of action of the N-terminal domain, our data show that current models for Anti-Smad function, in which the C-terminal domain binds to TGF-b family receptors, signal transducing Smads, or transcription factors are not adequate to explain the full in vivo activities of these molecules.
Experimental procedures
Embryo culture and manipulation
Xenopus eggs were obtained, and embryos were injected and cultured as described (Moon and Christian, 1989) .
Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967) . Animal caps were isolated and cultured as described (Nakayama et al., 1998a,b) .
Plasmid construction and RNA synthesis
All constructs were derived from the previously described plasmids pCS21Smad7, pCS21Smad6, or pCS21Smad6-myc (Nakayama et al., 1998a,b) . Smad7 IntD encodes a Smad7 variant which lacks 43 amino acids from the linker domain. An appropriate restriction fragment from a cDNA (accession number AJ001375) containing an in frame internal 129-bp deletion (a kind gift from Dr. Kenji Okazaki, Biomolecular Engineering Research Institute, Osaka, Japan) was subcloned in place of the corresponding region of full length pCS21Smad7. Other mutant and chimeric forms of Smad6 and Smad7 were generated by cut-and-paste using restriction sites that were naturally present in the cDNAs and/or that were arti®cially introduced by polymerase chain reaction (PCR)-based techniques. The resultant constructs were sequenced to con®rm that only the intended changes in sequence were introduced. Capped synthetic RNA was generated by in vitro transcription of linearized templates using a Megascript kit (Ambion).
Semi-quantitative reverse transcription-PCR (RT-PCR)
RNA was isolated from pooled (at least 10) animal caps or embryos and semi-quantitative RT-PCR analysis was performed as described (Nakayama et al., 1998a,b) using the following PCR conditions: 948C for 5 min, followed by a variable number of cycles (determined empirically to be in the linear range for each primer pair using RT product of control embryo RNA) at 948C for 30 s; 558C for 30 s and 728C for 30 s. EF1-a, NCAM, and a-actin primers have been reported (Nakayama et al., 1998a,b) . For detection of 6£ myc epitope tag sequence, the following primers were used: downward, 5 H -CGATTTAAAGCTATGGAG-3 H ; upward, 5 H -AATACGACTCACTATAG-3 H ( T7 primer). PCR products were visualized and quanti®ed with a Molecular Dynamics phosphorimager.
Western blot analysis
Proteins were extracted from pooled embryos (at least 10) as described (Moon and Christian, 1989) . Total protein of three embryo equivalents was separated by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membrane. Membranes were incubated with monoclonal antibody 9E10 to detect the myc-epitope, followed by horseradish peroxidase-conjugated secondary antibody and chemiluminescent detection using an ECL kit (Pierce) as described (Tian et al., 1999) . The same membrane was stained with Fast Green to con®rm equal loading and transfer of samples.
